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During pregnancy, the regulation of several neuroendocrine systems are altered to support the 3 
pregnancy and facilitate the transition to motherhood. These adaptations are organised by the 4 
mother’s brain and include those that serve to optimise fetal growth, protect the fetus(es) from 5 
adverse prenatal programming by maternal stress, facilitate timely parturition and ensure the 6 
offspring are nourished and cared for after birth. Although pregnancy hormones are important in 7 
inducing and maintaining many of these adaptations, their effects are often mediated via interactions 8 
with neuropeptide systems in the brain. In particular, endogenous opioids in the maternal brain play 9 
key roles in altered regulation of the stress axis, the oxytocin system, the prolactin system and in the 10 
neural circuits controlling maternal behaviour. Together these adaptations maximise the likelihood of 11 





During pregnancy altered neuropeptide signalling in the maternal brain allows physiological 15 
adaptations that maximise the likelihood of a successful pregnancy outcome. Several neuroendocrine 16 
systems are modified in pregnancy. For example, oxytocin stores in the posterior pituitary are 17 
enlarged so there are sufficient reserves to meet the demand at parturition and during lactation. At 18 
the same time oxytocin neurones have to be kept in check to prevent premature activation and 19 
minimise the risk of preterm birth. Exposure of the developing fetus to maternal stress hormones can 20 
lead to intra-uterine growth restriction and have long term adverse effects on the fetal brain, hence 21 
maternal stress responses are restrained in pregnancy to conserve energy and protect the fetus. The 22 
central control of prolactin secretion is altered so a state of hyperprolactinemia can develop to support 23 
milk production and secretion, to sustain lactation and nourish the offspring. To facilitate the 24 
transition to motherhood, the neural circuits governing maternal behaviour are primed to ensure the 25 
rapid expression of appropriate maternal care after birth. These adaptations are driven primarily by 26 
the actions of pregnancy hormones on the brain; however endogenous opioid mechanisms play 27 
important regulatory roles in these systems. Here, focussing on the rodent literature, we consider the 28 
contribution of endogenous opioids in mediating critical changes in the maternal brain that support 29 
the pregnancy, prepare females for birth and motherhood.  30 
 31 
Endogenous opioids 32 
 33 
There are three families of endogenous opioids: the enkephalins, dynorphins and endorphins, each 34 
derived from different precursors: proenkephalin (pENK), prodynorphin (pDYN) and 35 
proopiomelanocortin (POMC), respectively (Drolet et al. 2001) and three main types of opioid 36 
receptor, referred to as mu (), delta () and kappa ()(Mansour et al. 1994a). Enkephalins bind to - 37 
and -receptors, dynorphins to -receptors and endorphins to - and - receptors (Russell and 38 
Douglas 2000). Endogenous opioids and their receptors are widely distributed throughout the CNS (Le 39 
Merrer et al. 2009) where they play an important role in regulating responses to stress, modulating 40 
pain, mood and emotionality, food intake, reward and attachment (Bali et al. 2015; Benarroch 2012; 41 
Bodnar 2011; Drolet et al. 2001). During pregnancy, endogenous opioids play key roles in promoting 42 
adaptations in the maternal brain, particularly in the arcuate, paraventricular and supraoptic nuclei 43 




The HPA axis  46 
 47 
The hypothalamo-pituitary-adrenal (HPA) axis is the major neuroendocrine system which responds to 48 
stress. Stress exposure results in activation of a population of neurosecretory neurones in the 49 
parvocellular region of the paraventricular nucleus (pPVN) in the hypothalamus which synthesise two 50 
neuropeptides: corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP). CRH and AVP 51 
are released from nerve terminals at the median eminence into the hypophysial portal blood system 52 
and act synergistically on anterior pituitary corticotrophs to stimulate ACTH secretion, which in turn 53 
triggers secretion of glucocorticoids from the adrenal cortex. Glucocorticoids play a vital role in 54 
restoring homeostasis in the face of stress by mediating appropriate behavioural and metabolic 55 
adaptations and also switch off the HPA axis, via a negative feedback loop, when the stress no longer 56 
poses a threat. 57 
 58 
Attenuated HPA axis responses in pregnancy 59 
 60 
In late pregnant rodents, the HPA axis is less responsive to a host of psychological and physical 61 
stressors, such as exposure to a novel environment, air-puff, the elevated plus maze, noise, social 62 
stress, forced swimming, immune challenge, as well as to stimulation by metabolic peptides or CRH; 63 
and this hyporesponsive state is maintained through parturition and lactation, until weaning (Brunton 64 
et al. 2006a; Brunton et al. 2005; Brunton and Russell 2003; Brunton and Russell 2010; da Costa et al. 65 
1997; Douglas et al. 2003; Ma et al. 2005; Neumann et al. 2003; Neumann et al. 1998; Shanks et al. 66 
1999; Toufexis et al. 1999; Windle et al. 1997). Hence, stress-induced ACTH and corticosterone 67 
secretion is markedly reduced or completely suppressed in late pregnancy and during lactation, as a 68 
result of adaptations at the level of both the anterior pituitary and the brain, though those in the 69 
hypothalamus seem to be of key importance (Brunton 2010). For example, stress is less effective in 70 
activating the parvocellular CRH/AVP neurones in the PVN, meaning activity of the HPA axis is 71 
restrained at the apex of the system (Brunton et al. 2005; da Costa et al. 2001; da Costa et al. 1996; 72 
Lightman and Young 1989). Importantly, this phenomenon of reduced glucocorticoid responses to 73 
stress is also observed in pregnant women (Kammerer et al. 2002; Schulte et al. 1990). It is thought 74 
that attenuated HPA axis responses to stress in pregnancy function to conserve energy supplies for 75 
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the pregnancy and minimise exposure of the fetus(es) to excessive levels of maternal glucocorticoids, 76 
which can have long-term adverse programming effects (Maccari et al. 2014).  77 
 78 
Endogenous opioids and regulation of the HPA axis 79 
 80 
Opioid synthesising neurones are present in stress-related regions of the brain including the cerebral 81 
cortex, amygdala, lateral septum, bed nucleus of the stria terminalis (BNST), preoptic area, 82 
hypothalamus, nucleus tractus solitarii (NTS) and ventrolateral medulla (VLM) (Harlan et al. 1987; 83 
Khachaturian et al. 1983). Several studies provide evidence for endogenous opioids in modulating 84 
behavioural and HPA axis responses to stress (Barfield et al. 2010; Brunton et al. 2005; Buckingham 85 
and Cooper 1986; Buller et al. 2005; Douglas et al. 1998a; Drolet et al. 2001; Grisel et al. 2008; Sanders 86 
et al. 2005) and acute stress results in an increase in gene expression for enkephalin in brain regions 87 
involved in stress processing, including the PVN and the brainstem (Ceccatelli and Orazzo 1993; Harbuz 88 
et al. 1994; Harbuz and Lightman 1989; Mansi et al. 2000). The effects of endogenous opioids in the 89 
brain on stress-related behaviours and neuroendocrine stress responses are complex, and region- and 90 
opioid receptor type-dependent. For example, there is evidence that endogenous endorphins and 91 
enkephalins aid stress-coping, particularly under chronic stress conditions, and have anxiolytic actions, 92 
whereas dynorphin has been demonstrated to have anxiogenic actions (Barfield et al. 2010; Berube 93 
et al. 2013; Berube et al. 2014; Grisel et al. 2008; Henry et al. 2018; Kang et al. 2000; Katoh et al. 1990; 94 
Konig et al. 1996), though these effects depend on the site of action in the brain. 95 
  96 
In male rats (and non-pregnant females), administration of an exogenous opioid receptor agonist (e.g. 97 
morphine) results in enhanced, while an opioid receptor antagonist (naloxone) suppresses HPA axis 98 
responses to acute stress (Buckingham and Cooper 1984, 1986; Buller et al. 2005). This is evidently 99 
the result of a central action, as morphine, met-enkephalin and leu-enkephalin stimulate CRH 100 
secretion from hypothalamic preparations, but not ACTH release from the pituitary (Buckingham and 101 
Cooper 1984) and centrally administered naloxone reduces stress-induced activation of CRH neurones 102 
in the pPVN (Buller et al. 2005). However in pregnancy, endogenous opioids switch to having a net 103 
inhibitory role over HPA axis function. 104 
 105 




Attenuated HPA axis responses to stress in pregnancy are a consequence of the emergence of a central 108 
inhibitory opioid mechanism. Hence, systemic administration of naloxone reinstates HPA axis 109 
responses to stressful stimuli, such as forced swimming and immune challenge in late pregnant rats 110 
(Brunton et al. 2005; Douglas et al. 1998a) and to parturition-related stimuli at birth (Wigger et al. 111 
1999), reflected by increased ACTH and corticosterone secretion, together with increased activation 112 
of pPVN neurones and increased gene expression for Crh in the pPVN (Brunton et al. 2005). 113 
 114 
In late pregnancy, gene expression for pENK-A (Penk) and µ–opioid receptor (MOR; Oprm1) are up-115 
regulated in the NTS of the brainstem and Pomc mRNA and β-endorphin immunoreactivity is increased 116 
in the arcuate nucleus compared with non-pregnant rats (Brunton et al. 2005; Douglas et al. 2002). 117 
However, it is likely that the NTS is the source of the opioids that are involved in restraining HPA axis 118 
responses in late pregnant rats, at least for those stressors where activation of the CRH neurones is 119 
mediated via brainstem afferents. The evidence is as follows: immune challenge with the cytokine, 120 
interleukin-1β (IL-1β) activates hypothalamic-projecting noradrenergic neurones in the A2 region of 121 
the NTS. This results in increased noradrenaline release from nerve terminals in the PVN which 122 
stimulates CRH neurones and hence ACTH and corticosterone secretion. In late pregnancy, despite 123 
similar activation of the NTS neurones, systemic IL-1β fails to result in increased noradrenaline release 124 
in the PVN. Similarly, noradrenaline release in the PVN evoked by forced swim stress is significantly 125 
lower in late pregnant rats compared with virgin females (Douglas et al. 1995).  Naloxone infused 126 
directly into the PVN restores IL-1β-induced noradrenaline release in the PVN (Brunton et al. 2005), 127 
indicating that endogenous opioids act presynaptically on noradrenergic inputs to the PVN to inhibit 128 
evoked noradrenaline release. If the noradrenergic NTS neurones are the same population that display 129 
increased gene expression for MORs and enkephalin in pregnancy, this would provide a mechanism 130 
whereby endogenous opioids (i.e. enkephalin) act on up-regulated presynaptic MORs on 131 
noradrenergic nerve terminals to auto-inhibit noradrenaline release in the PVN (Fig. 2), hence 132 
reducing stimulation of the CRH neurones in late pregnancy (Brunton et al. 2005). The same 133 
mechanism is hypothesised to limit activation of the magnocellular oxytocin neurones in late 134 
pregnancy (see below)(Brunton et al. 2006b; Leng et al. 1995). 135 
 136 
A reduction in the effectiveness of the noradrenergic input to the pPVN CRH neurones has also been 137 
implicated in underlying reduced HPA axis responses to stress during lactation (Toufexis et al. 1998; 138 
Toufexis and Walker 1996), however the precise mechanisms are not known. However, in contrast to 139 
pregnancy and parturition, HPA axis hyporesponsiveness during lactation is dependent upon the 140 
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suckling stimulus provided by the pups (Lightman and Young 1989) and is likely to involve central 141 




Oxytocin is synthesised by magnocellular neurones in the PVN and the supraoptic nuclei (SON), whose 146 
axons project to the posterior pituitary gland (Russell and Brunton 2009). Upon activation, oxytocin is 147 
secreted from the nerve terminals in the posterior pituitary into the systemic circulation. Oxytocin 148 
plays an important role in promoting uterine contractions during at birth and is vital in stimulating 149 
milk ejection during lactation (for review see (Burbach 2006)). Oxytocin is also released within the 150 
brain from the dendrites of the magnocellular neurones and also from the terminals of centrally 151 
projecting neurones, where it plays an important role in promoting the expression of maternal 152 
behaviour after birth (Knobloch et al. 2012; Lee et al. 2009; Ludwig and Leng 2006; Pedersen et al. 153 
1994). In the rat, oxytocin is also considered to be a ‘stress hormone’; hence stress exposure activates 154 
oxytocin neurones (reflected by increased expression of the protein product of the immediate early 155 
gene, c-fos) and stimulates oxytocin secretion (Brunton et al. 2006b; Douglas et al. 2000; Lang et al. 156 
1983). 157 
   158 
During pregnancy, the oxytocin neurones are maintained in a quiescent state that limits oxytocin 159 
secretion and permits the accumulation of oxytocin stores in the posterior pituitary (which expand by 160 
around 75% in rats) (Douglas et al. 1993b; Fuchs and Saito 1971), for when it is required at parturition 161 
and subsequent lactation. Accruing these stores is important as oxytocin synthesis is evidently not 162 
increased in pregnancy (Douglas et al. 1998b). Critically, limiting activity of the oxytocin neurones in 163 
pregnancy also minimises the likelihood of premature oxytocin secretion that could lead to uterine 164 
contractions and preterm birth (Elovitz and Mrinalini 2004; Goodwin et al. 1994). There are several 165 
mechanisms that contribute to restraining oxytocin secretion during pregnancy (Brunton et al. 2013). 166 
These include auto-inhibition by nitric oxide (Srisawat et al. 2000) and the potentiating effects of 167 
allopregnanolone on GABA actions at GABAA receptors (Brussaard and Herbison 2000), however here 168 
the focus is on endogenous opioid mechanisms. 169 
 170 




A2 noradrenergic neurones in the NTS of the brainstem project to magnocellular oxytocin neurones 173 
in the SON and PVN (Ericsson et al. 1994; Meddle et al. 2000) . At parturition, noradrenaline release is 174 
increased in the SON and PVN and acts on α1 adrenoceptors to activate the oxytocin neurones 175 
(Douglas et al. 1998b; Douglas et al. 2001; Herbison et al. 1997; Meddle et al. 2000; Randle et al. 1986). 176 
Activated oxytocin neurones fire in synchronised bursts, secreting pulses of oxytocin into the blood 177 
which acts on myometrium oxytocin receptors (OTR), up-regulated by increased levels of estradiol 178 
acting on estrogen receptor-α (ERα) (Mesiano et al. 2002; Murata et al. 2000; Murata et al. 2003; 179 
Welsh et al. 2012), to stimulate uterine contractions. Signals from the contracting uterus and 180 
distended birth canal are relayed by spinal and vagal afferents (Higuchi et al. 1986; Peters et al. 1987) 181 
to the A2 noradrenergic NTS neurones, resulting in a positive feedback loop which drives further 182 
oxytocin release, known as the Ferguson reflex (Ferguson 1941). Oxytocin release from the dendrites 183 
of activated magnocellular neurones acts locally to synchronise burst firing of the oxytocin neurones, 184 
necessary for pulsatile oxytocin secretion at parturition and during milk-ejection (Dyball and Leng 185 
1986; Moos et al. 1998; Rossoni et al. 2008).  186 
 187 
Endogenous opioids and control of oxytocin secretion  188 
 189 
Oxytocin secretion is restrained by endogenous opioids. Opioids act both centrally, on the oxytocin 190 
neurones or their inputs, as well as on axon terminals in the posterior pituitary (Bicknell et al. 1988; 191 
Zhao et al. 1988a, b). In non-pregnant rats and during early pregnancy, endogenous opioids acting via 192 
κ-opioid receptors on axon terminals in the posterior pituitary inhibit oxytocin secretion and this is 193 
the principal mechanism involved in regulating oxytocin secretion (Douglas et al. 1993b; Leng et al. 194 
1994). However, during the last week of pregnancy, a κ-agonist is less effective in inhibiting electrically 195 
stimulated oxytocin release from isolated neural lobes, indicating a desensitisation of this inhibitory 196 
opioid mechanism in the pituitary (Douglas et al. 1993b), allowing for enhanced oxytocin secretion at 197 
parturition in response to excitation of the oxytocin cell bodies. At this time a central inhibitory opioid 198 
system becomes activated (described below), and this mechanism predominates in restraining activity 199 
of the oxytocin neurones in response to excitatory stimuli in late pregnancy (Douglas et al. 1993b; 200 
Douglas et al. 1995). 201 
 202 




In non-pregnant rats, in addition to activating the HPA axis, systemic IL-1β also activates oxytocin 205 
neurones, increasing their firing rate and resulting in increased oxytocin secretion into the blood 206 
(Brunton et al. 2012; Brunton et al. 2006b). In contrast, IL-1β has no effect on the electrical or secretory 207 
activity of oxytocin neurones in late pregnant rats (Brunton et al. 2012; Brunton et al. 2006b). This is 208 
the result of a central endogenous opioid mechanism, since naloxone increases the firing rate of 209 
oxytocin neurones and unmasks a much exaggerated oxytocin secretory response to IL-1β and in late 210 
pregnant rats (Brunton et al. 2006b). A similar response is seen following forced swimming or CCK 211 
administration, where oxytocin secretion, Fos induction in the SON neurones and the firing rate of 212 
oxytocin neurones in the SON is potentiated by naloxone to a far greater extent in late pregnant rats 213 
compared with virgin females (Douglas et al. 1998a; Douglas et al. 1995). Forced swimming, CCK and 214 
IL-1β mediate their excitatory effect on oxytocin neurones via noradrenergic neurones in the NTS. As 215 
mentioned above, in late pregnancy these stimuli fail to trigger noradrenaline release in the PVN 216 
(Brunton et al. 2005; Douglas et al. 2005). It is proposed that the same endogenous opioid mechanism 217 
that prevents excitation of the CRH neurones in the PVN (described above) by inhibiting noradrenaline 218 
release from afferent inputs to the PVN (mediated by enkephalin actions on presynaptic MORs) also 219 
serves to keep the oxytocin neurones in the SON and PVN under control in late pregnancy (Fig. 2). 220 
Given that A2 noradrenergic NTS neurones also relay stimuli from the birth canal to drive oxytocin 221 
secretion at parturition, it is hypothesised that maintaining quiescence of this pathway during 222 
pregnancy plays an important role in preventing premature activation of the oxytocin neurones and 223 
ensuring birth is not triggered prematurely.  224 
 225 
While this inhibitory opioid mechanism is anticipated to prevent inappropriate activation of the 226 
oxytocin neurones by stimuli such as stress in late pregnancy, central opioid inhibition of the oxytocin 227 
neurones persists during parturition (Leng et al. 1988; Neumann et al. 1991), but is withdrawn soon 228 
after birth (Leng et al. 1988) and is not detected in lactation (Douglas et al. 1993b; Neumann et al. 229 
1993). µ- and κ-receptor agonists inhibit the electrical activity of oxytocin neurones, inhibit oxytocin 230 
secretion and delay established parturition (Bicknell et al. 1988; Douglas et al. 1993a; Leng et al. 1988; 231 
Pumford et al. 1991; Pumford et al. 1993; Russell et al. 1989). Conversely naloxone administration 232 
during parturition increases oxytocin secretion and reduces the interval between pup births (Leng et 233 
al. 1988). Similarly, naloxone can prevent the reduction in oxytocin secretion and the interruption to 234 
parturition induced by stress (Leng et al. 1988). Together these data indicate potent opioid inhibition 235 
over oxytocin neurones at parturition, which may serve to regulate the timing of births so inter-birth 236 




Endogenous opioids also restrain oxytocin release within the SON and PVN in late pregnancy, however 239 
this mechanism is down-regulated at parturition (Douglas et al. 1995; Neumann et al. 1993). Given 240 
local oxytocin release within the magnocellular nuclei plays an important role in positive feedback 241 
regulation of oxytocin neuronal activity (Neumann et al. 1996), withdrawal of this opioid inhibition 242 
permits potent excitation of the oxytocin neurones and promotes synchronised burst firing of oxytocin 243 
neurones during parturition and suckling for effective uterine contractions and milk ejection.  244 
 245 
Induction of inhibitory endogenous opioid tone over HPA axis and oxytocin responses in pregnancy 246 
 247 
The endogenous opioid mechanism that restrains activity of the HPA axis and magnocellular oxytocin 248 
system in pregnancy is induced by the neuroactive metabolite of progesterone, allopregnanolone 249 
(Brunton et al. 2012; Brunton et al. 2009). Allopregnanolone concentrations progressively increase in 250 
the blood and in the brain during pregnancy (Concas et al. 1998). In the brain, allopregnanolone 251 
concentrations reach maximal levels in late pregnancy, before declining dramatically before 252 
parturition (Concas et al. 1998).  Gene expression for 5α-reductase (Srd5a) and 3α-hydroxysteroid 253 
dehydrogenase (Akr1c4), the enzymes responsible for the conversion of progesterone to 254 
dihydroprogesterone and then allopregnanolone, are up-regulated in the NTS in late pregnancy 255 
(Brunton et al. 2009) and activity of these enzymes is also increased in the hypothalamus of late 256 
pregnant rats (Brunton et al. 2009); presumably leading to increased local allopregnanolone synthesis. 257 
Blocking allopregnanolone synthesis in pregnant rats with the 5α-reductase inhibitor, finasteride, not 258 
only restores ACTH and oxytocin secretory responses to immune challenge, but reduces Penk gene 259 
expression in the NTS to levels similar to those found in non-pregnant animals (Brunton et al. 2012; 260 
Brunton et al. 2009). Moreover, administration of allopregnanolone to virgin rats (to simulate 261 
pregnancy levels) rapidly up-regulates Penk gene expression in the NTS to levels equivalent to those 262 
observed in late gestation and induces opioid inhibition over stress-induced ACTH and oxytocin 263 
secretion (Brunton et al. 2012; Brunton et al. 2009). Hence, increased concentrations of 264 
allopregnanolone in the NTS in pregnancy evidently induce and maintain an inhibitory opioid 265 
mechanism that tightly controls both the oxytocin and the CRH neurones. This is important since 266 
inhibiting 5α-reductase activity (and hence allopregnanolone production) during the last week of 267 
gestation leads to preterm birth and increased neonatal mortality (Paris et al. 2011). It remains to be 268 
established whether this is a result of premature activation of the oxytocin neurones as a result of 269 
withdrawal of endogenous opioid tone or is due to altered GABA signalling to oxytocin neurones, since 270 
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allopregnanolone has also been demonstrated to potentiate the inhibitory influence of GABA on 271 
oxytocin neurones in late pregnancy (Koksma et al. 2003).   272 
 273 
Mimicking pregnancy levels of sex steroids in virgin females with chronic estradiol and progesterone 274 
administration induces opioid inhibition over the neurohypophysial oxytocin system, but not the HPA 275 
axis (Douglas et al. 2000). Hence naloxone administration potentiates stress-induced oxytocin 276 
secretion, but not ACTH or corticosterone in these rats (Douglas et al. 2000). It is unclear why this 277 
treatment induces opioid tone over the oxytocin system but not the HPA axis. It is not known whether 278 
exogenously administered progesterone is converted to allopregnanolone to exert these effects, 279 
though this seems unlikely as this would be expected to result in similar effects on both systems 280 
(Brunton et al. 2012; Brunton et al. 2009). Rather, it is possible that the sex steroid treatment expands 281 
pituitary stores of oxytocin (as in pregnancy) meaning a greater pool is available for release when 282 
opioid restraint is blocked by naloxone.  283 
  284 
Central control of prolactin secretion 285 
 286 
In non-pregnant animals, prolactin secretion by anterior pituitary lactotrophs is under tonic inhibitory 287 
control by dopamine, produced and secreted by hypothalamic tubero-infundibular dopamine (TIDA) 288 
neurones in the arcuate nucleus neurones which project to the median eminence and secrete 289 
dopamine into the hypothalamo-hypophysial portal blood system (Reymond and Porter 1985). In the 290 
anterior pituitary, dopamine acts on D2 receptors expressed on lactotrophs to inhibit prolactin 291 
production (Caron et al. 1978; Guillou et al. 2015; Mansour et al. 1990). Prolactin can enter the brain 292 
(Walsh et al. 1987); however the process by which it crosses the blood-brain barrier is unclear, 293 
although evidently this does not depend upon prolactin receptors (PRL-R) (Brown et al. 2016). Once 294 
in the brain, prolactin acts directly on TIDA neurones, which express PRL-Rs, to stimulate activity of 295 
the TIDA neurones and up-regulate tyrosine hydroxylase (Th; the rate-limiting enzyme in dopamine 296 
synthesis) gene expression in TIDA neurones (Arbogast and Voogt 1991; Lerant and Freeman 1998). 297 
This results in increased dopamine synthesis and secretion into the portal blood generating a short-298 
loop negative-feedback system whereby prolactin controls its own secretion (Ben-Jonathan et al. 299 
1980).  300 
 301 




In the rat, prolactin plays an essential role in preventing regression of the corpus luteum (luteolysis) 304 
in early pregnancy, ensuring progesterone secretion to sustain the pregnancy and in preparing the 305 
mammary alveoli for milk production (Gibori and Richards 1978; Ormandy et al. 1997). In addition, 306 
prolactin (together with estrogen, progesterone and oxytocin) primes the brain to promote maternal 307 
behaviour after birth and plays an essential role in lactation by stimulating milk production and 308 
secretion (Bridges et al. 1985; Bridges et al. 1990; Bridges and Ronsheim 1990; Lucas et al. 1998; 309 
Ormandy et al. 1997). Moreover, increased prolactin in the maternal brain in the perinatal period 310 
contributes to restraining basal and stress-induced activity of the HPA axis and oxytocin system 311 
(Gustafson et al. 2017; Torner et al. 2002). Accordingly, in pregnancy, there are important adaptations 312 
in the hypothalamic mechanisms controlling the prolactin system that must occur in order to facilitate 313 
increased prolactin secretion. 314 
 315 
In rodents, mating stimulates the onset of twice daily surges in prolactin secretion which persist for 316 
the first 8-10 days of pregnancy (Gunnet and Freeman 1983). Around mid-pregnancy, these surges are 317 
suppressed when the secretion of placental lactogen begins to increase which acts in a similar fashion 318 
to prolactin to stimulate dopamine release from TIDA neurones and thereby inhibit prolactin secretion 319 
from the lactotrophs (Demarest et al. 1983a; Lee and Voogt 1999; Smith and Neill 1976; Voogt et al. 320 
1982; Voogt 1984). The night before parturition and following progesterone withdrawal, the TIDA 321 
neurones become seemingly insensitive to negative feedback by prolactin and placental lactogen─ 322 
despite increasing their firing rate, they fail to secrete dopamine in response to prolactin (Anderson 323 
et al. 2006a; Romano et al. 2013) and this persists into lactation.  This ineffective negative feedback 324 
permits a large nocturnal surge in prolactin secretion at the end of pregnancy, facilitating the 325 
transition from gestation to motherhood and allowing a state of hyperprolactinemia to develop to 326 
sustain lactation (Grattan and Averill 1990; Grattan et al. 2008).  The mechanism involved is not fully 327 
understood, but is evidently induced by progesterone withdrawal (Grattan and Averill 1990; Soaje et 328 
al. 2006) and probably involves changes in prolactin receptor intracellular signalling and reduced TH 329 
activity (Anderson et al. 2006a; Anderson et al. 2006b; Steyn et al. 2008). Following parturition, 330 
suckling by the pups reduces activity of the TIDA neurones, down-regulates Th gene expression and 331 
suppresses dopamine release at the median eminence, hence increasing prolactin secretion until 332 
weaning when tonic inhibition of prolactin secretion by TIDA neurones is reinstated (Ben-Jonathan et 333 
al. 1980; Demarest et al. 1983b; Feher et al. 2010; Selmanoff and Gregerson 1985; Selmanoff and Wise 334 




Endogenous opioids and regulation of prolactin secretion during pregnancy and lactation 337 
  338 
Endogenous opioids play a key role in regulating prolactin secretion by the pituitary through actions 339 
on TIDA neurones. Endogenous opioid peptides inhibit TIDA neurones and hence dopamine secretion, 340 
promoting the prolactin surges in early pregnancy and pre-partum, and suckling-induced prolactin 341 
secretion during lactation (Andrews and Grattan 2002, 2003; Callahan et al. 2000; Sagrillo and Voogt 342 
1991). Hence, naloxone administration during the night before parturition increases dopamine 343 
turnover and inhibits the pre-partum prolactin surge (Andrews and Grattan 2002). Interestingly, 344 
treatment with naloxone a couple of days earlier in pregnancy (on day 19) has no effect on prolactin 345 
secretion or dopaminergic activity in the mediobasal hypothalamus (Soaje et al. 2006), unless 346 
progesterone actions are blocked, which decreases TIDA neurone activity and permits an increase in 347 
prolactin secretion (Soaje et al. 2006), supporting the idea that progesterone withdrawal at the end 348 
of pregnancy plays a key role in reducing activity of the TIDA neurones and facilitating increased 349 
prolactin secretion (Andrews and Grattan 2002; Soaje and Deis 1994). However, on day 19 of 350 
pregnancy, despite facilitating increased prolactin secretion, naloxone has no greater effect on the 351 
activity of the dopamine neurones than the anti-progesterone given alone (Soaje et al. 2006), 352 
suggesting that in addition to the inhibition of TIDA neurones, endogenous opioids may regulate 353 
prolactin secretion through another mechanism in the presence of high levels of progesterone, 354 
possibly via inhibition of putative prolactin-releasing factor neurones. One such candidate is oxytocin 355 
since, oxytocin stimulates prolactin secretion (Gonzalez-Iglesias et al. 2015; Samson et al. 1986) and 356 
as described above, oxytocin neurones are inhibited by endogenous opioids in late pregnancy 357 
(Brunton et al. 2006b; Douglas et al. 2000). Indeed, recent findings support a role for oxytocin in 358 
facilitating prolactin secretion in late pregnancy, but this effect is only apparent when progesterone 359 
action is blocked (Villegas-Gabutti et al. 2018). 360 
      361 
Immunoreactivity for dynorphin, enkephalins and β-endorphin is present in the arcuate nucleus 362 
(Fitzsimmons et al. 1992; Merchenthaler 1994) and contact between opioid peptide-containing nerve 363 
terminals and TIDA neurones has been described (Fitzsimmons et al. 1992; Horvath et al. 1992). 364 
However, β-endorphin innervation of dopaminergic neurones only represents a small proportion of 365 
opioidergic connections in the arcuate nucleus, with the majority expressing dynorphin or enkephalin 366 
(Fitzsimmons et al. 1992). During pregnancy and lactation, POMC mRNA expression and β-endorphin 367 
immunoreactivity are only modestly increased in the arcuate nucleus in late pregnancy (Douglas et al. 368 
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2002), however immunoreactivity and gene expression for enkephalin is markedly up-regulated, such 369 
that all TIDA neurones co-express enkephalin (Merchenthaler 1994; Merchenthaler et al. 1995), which 370 
is likely driven by increased prolactin (Nahi and Arbogast 2003). Given the lack of δ-receptors in the 371 
arcuate nucleus (Mansour et al. 1994a; Mansour et al. 1987), it is reasonable to assume that 372 
enkephalin released from TIDA neurones acts on µ-opioid receptors in the arcuate nucleus, perhaps 373 
in an auto-inhibitory manner (Fig. 3). Indeed, the prolactin surges in early pregnancy, late pregnancy 374 
and lactation are inhibited and the activity of TIDA neurones increased, by administration of selective 375 
µ- and -, but not -receptor antagonists (Andrews and Grattan 2003), indicating these receptors play 376 
more important roles. 377 
   378 
In late pregnancy, in addition to attenuating HPA axis and oxytocin responses to stress, endogenous 379 
opioids also restrain stress-induced prolactin secretion (Valdez et al. 2014). This effect is mediated 380 
through μ opioid receptors and estradiol and progesterone actions are involved in the induction and 381 
maintenance of this inhibitory opioid tone (Valdez et al. 2014).  Hence, in pregnancy endogenous 382 
opioids, through their inhibitory actions on TIDA neurones, play a key role in permitting a state of 383 
hyperprolactinemia which maintains the pregnancy and facilitates lactation. In addition, prolactin 384 
actions on the brain also promotes maternal behaviour post-partum (discussed below). 385 
 386 
Maternal behaviour 387 
 388 
Following the birth of the offspring, maternal behaviour must be expressed swiftly if the young are to 389 
be reared successfully. Maternal care consists of a complex set of behaviours including nest-building, 390 
retrieving and gathering the young, nursing, grooming and protection from the environment (e.g. cold) 391 
and other threats (e.g. unfamiliar conspecifics). The maternal brain is primed for this transition by 392 
prolonged exposure to pregnancy levels of ovarian and lactogenic hormones during gestation (for 393 
review see (Bridges 2015)).  394 
 395 
Neural circuitry and hormonal priming of maternal behaviour 396 
 397 
The different elements of maternal behaviour involve distinct, though interconnected circuits in the 398 
brain (for review see (Numan 2007)). Of particular importance in the onset and integration of maternal 399 
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behavioural responses is the medial preoptic area (mPOA), hence lesions to this region disrupt or 400 
abolish maternal behaviour (Cohn and Gerall 1989; Numan et al. 1977; Numan and Smith 1984; Stack 401 
et al. 2002; Tsuneoka et al. 2013). Hormone priming mediated by the decline in circulating 402 
progesterone at the end of pregnancy, concurrent with increased estradiol activates neurones in the 403 
mPOA and induces maternal behaviour (Bridges et al. 1978; Sheehan and Numan 2002) and maternal 404 
behaviour can be induced in nulliparous rats treated with sex steroids to mimic the concentrations 405 
and pattern of secretion seen in pregnancy (Bridges 1984). Activation of the mPOA and the 406 
neighbouring ventral BNST, results in inhibition of neural circuits involving the anterior hypothalamic 407 
nucleus and the periaqueductal grey, that normally mediate aversive responses to newborn pups and 408 
pup odour in virgin females, thus eliminating avoidance behaviour (Bridges et al. 1999; Numan and 409 
Numan 1996; Sukikara et al. 2006); and activation of dopaminergic neurones in the ventral tegmental 410 
area (VTA) project to the nucleus accumbens (NAc) to stimulate motivation and reward, making new 411 
mothers more responsive to pup-related stimuli (Champagne et al. 2004; Hansen et al. 1991; Keer and 412 
Stern 1999; Numan and Smith 1984; Parada et al. 2008; Stolzenberg et al. 2007).  413 
 414 
Prolactin and oxytocin also play key roles in stimulating maternal care. Central prolactin infusions 415 
stimulate maternal behaviour towards foster pups in steroid-primed virgin rats and prolactin is more 416 
effective when administered directly into the MPOA (Bridges et al. 1990); while suppression of 417 
endogenous prolactin secretion with bromocriptine delays the onset of maternal behavior (Bridges 418 
and Ronsheim 1990). Moreover, a recent study employing conditional PRL-R knockout mice 419 
demonstrate prolactin action, specifically in the MPOA, is vital for the normal expression of maternal 420 
behavior after birth (Brown et al. 2017). At parturition, oxytocin receptors are up-regulated in several 421 
brain regions linked to maternal behaviour, including in the MPOA, BNST and VTA (Meddle et al. 2007; 422 
Pedersen et al. 1994). Administration of an oxytocin receptor antagonist into the VTA or the MPOA of 423 
parturient impairs maternal behaviour (Pedersen et al. 1994) and central administered exogenous 424 
oxytocin is able to induce maternal care in hormonally primed nulliparous rats (Pedersen et al. 1982).  425 
 426 
Endogenous opioids and maternal behaviour 427 
 428 
At parturition, the withdrawal of up-regulated central endogenous opioid mechanisms, in particular 429 
in the mPOA, is necessary to facilitate maternal behaviour (Byrnes and Bridges 2000; Byrnes et al. 430 
2000). Levels of opioids and opioid receptor binding sites in the MPOA are elevated during pregnancy, 431 
but decrease in lactation; evidently as a result of changes in ovarian sex steroids (Hammer Jr and 432 
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Bridges 1987). Administration of morphine or the μ-receptor agonist, β-endorphin (but not δ or K-433 
receptor agonists), into the MPOA disrupts maternal behaviour in lactating or hormone-primed 434 
sensitised virgin rats (Mann and Bridges 1992; Mann et al. 1991; Rubin and Bridges 1984). The role of 435 
physiological levels of endogenous opioids in the maternal brain post-partum is unclear, however 436 
there is evidence to indicate they may act to regulate nursing bout duration, at least in early lactation 437 
(Byrnes et al. 2000) and are involved in regulating the switch from nursing behaviour to 438 
predatory/hunting behaviour (Sukikara et al. 2007).  439 
 440 
Large scale gene expression studies of the MPOA, medial prefrontal cortex, lateral septum and NAc 441 
have identified over 1000 genes/region that are differentially expressed in the maternal brain 442 
compared with non-pregnant females (Driessen et al. 2014; Eisinger et al. 2014; Eisinger et al. 2013; 443 
Zhao et al. 2014). As well as identifying potential new candidate genes involved in regulating maternal 444 
behaviour, studies such as these are paving the way for exploring the networks and interactions 445 
between novel genes and the already well-characterised ‘maternal’ genes.  Post-partum dams find 446 
pups rewarding (Ferris et al. 2005; Lee et al. 2000), therefore it is particularly interesting that the top 447 
700 of the identified ‘maternal genes’ are significantly enriched for genes involved in reward and 448 
addiction, including genes for the opioid peptides, Penk and prodynorphin (Pdyn) and Oprm1 (Gammie 449 
et al. 2016), further supporting the hypothesis that endogenous opioid mechanisms play a role in 450 




In summary, endogenous opioids play key roles in mediating adaptations in the maternal brain. Here 455 
the focus was on adaptations in the regulation of the HPA axis, oxytocin system, prolactin system and 456 
the circuits governing maternal behaviour. These changes are important for conserving energy, 457 
protecting the fetus from harmful levels of maternal glucocorticoids, providing sufficient oxytocin for 458 
parturition and lactation, ensuring the onset of parturition occurs in a timely manner and that after 459 
birth the offspring are suckled and properly cared for. Appropriate withdrawal of up-regulated central 460 
endogenous opioid mechanisms is equally important to support the transition from pregnancy to 461 
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FIGURE LEGENDS 472 
Figure 1 : Anatomical distribution of opioid peptides and receptors in the arcuate, paraventricular 473 
and supraoptic nuclei of the rat hypothalamus 474 
The left-hand side of the diagram summarises the distribution of immunoreactivity for dynorphin 475 
(dyn), enkephalin (enk) and β-endorphin (βend) in cell bodies (stars) or in neuronal fibres (circles). The 476 
right-hand side shows the distribution pattern for mu (µ), delta () and kappa () opioid receptors. For 477 
cell bodies (stars) receptors were identified by in situ hybridisation; while receptor binding (triangles) 478 
was identified by autoradiography. In both cases, the relative expression levels are indicted by the 479 
number of a given symbol i.e. one symbol = low; 2 symbols = moderate; and 3 symbols = high 480 
expression. 3V, 3rd ventricle; Arc, arcuate nucleus; OT, optic tract; PVN, paraventricular nucleus; SON, 481 
supraoptic nucleus. Based on data from: (Abe et al. 1987; Beaulieu et al. 1996; Desjardins et al. 1990; 482 
Fallon and Leslie 1986; Khachaturian et al. 1983; Khachaturian et al. 1982; Mansour et al. 1994a; 483 
Mansour et al. 1994b; Mansour et al. 1994c; Mansour et al. 1987; Merchenthaler et al. 1986; Minami 484 
et al. 1994; Wamsley et al. 1980). 485 
Figure 2:  Endogenous opioid inhibition of CRH/oxytocin neurones in late pregnancy 486 
Noradrenergic (NAergic) A2 neurones in the nucleus tractus solitarii (NTS) of the brainstem project to 487 
parvocellular corticotropin-releasing hormone (CRH) and magnocellular oxytocin (OT) neurones in the 488 
paraventricular nucleus (PVN). In non-pregnant rats, stress (e.g. interleukin-1β, forced swimming) 489 
activates these noradrenergic A2 neurones triggering noradrenaline (NA) release from the nerve 490 
terminals in the PVN. Noradrenaline acts via 1 adrenoceptors (α1R) to stimulate (+) the CRH/OT 491 
neurones, resulting in CRH release at the median eminence (ME) and OT release from the posterior 492 
pituitary (PP). In late pregnancy, systemic interleukin-1 fails to stimulate noradrenaline release in the 493 
PVN (despite similar activation of the noradrenergic cell bodies in the NTS); hence the CRH and OT 494 
neurones are less excited and ACTH/corticosterone and OT secretion is markedly suppressed () or 495 
completely absent. This is a consequence of increased inhibition (-) by a central endogenous opioid 496 
mechanism. It is proposed that enkephalin (enk) acts presynaptically on up-regulated MOR on the 497 
noradrenergic terminals to inhibit stimulated noradrenaline release, since the NTS A2 neurones 498 
display increased (↑) expression of proenkephalin-A and MOR mRNA in late pregnancy and infusion 499 
of the opioid receptor antagonist naloxone directly into the PVN restores IL-1β-evoked noradrenaline 500 
release in the PVN. Moreover naloxone activates the CRH and oxytocin neurones leading to increased 501 
ACTH, corticosterone and oxytocin secretion into the blood. 502 
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Figure 3: Endogenous opioid control of TIDA neurones in late pregnancy 503 
In virgin rats prolactin secretion is under tonic inhibition (-) by dopamine (DA) secreted by tubero-504 
infundibular dopamine (TIDA) neurones in the arcuate nucleus and secreted into the portal blood 505 
system to act on dopamine D2 receptors expressed on lactotrophs in the anterior pituitary. Prolactin 506 
acts via prolactin receptors (PRL-R) on TIDA neurons to stimulate (+) dopamine release, producing a 507 
short-loop negative-feedback system. Endogenous opioids inhibit TIDA neurones and hence stimulate 508 
prolactin secretion; this facilitates the surges in prolactin secretion in early pregnancy and pre-partum. 509 
Enkephalin (enk) is markedly up-regulated () in arcuate nucleus TIDA neurones in late pregnancy 510 
and it is proposed that enkephalin released from TIDA neurones acts on µ-/-opioid receptors to 511 
inhibit the dopamine neurones and hence dopamine release (possibly via auto-inhibition). Dynorphin 512 
(dyn) containing nerve terminals also make contact with arcuate TIDA neurones and dynorphin acts 513 
via -opioid receptors to inhibit TIDA neurones. In addition, before parturition, the TIDA neurones 514 
become insensitive to negative feedback by prolactin and placental lactogen (PL). These adaptations 515 
permit a state of hyperprolactinemia to develop which supports lactation and promotes maternal 516 
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